Lomustine has been used for over 40 years to treat brain tumors, Hodgkin's disease, lung, stomach, intestinal, kidney and myeloma cancers. In 2013, Bristol-Myers Squibb (USA) sold lomustine to NextSource Biotechnology (USA), a startup, at that time the drug was sold under the CeeNU trademark and cost $50 per capsule. The new owner renamed the drug Gleostine and today the same dosage costs $768.
The patent for lomustine expired (apparently, almost 30 years ago), but there are no analogues in the United States.
And after this capitalists ask why people want to do rough things to them.
Hanging them is a good way of compensation.
It looks like you're new here. If you want to get involved, click one of these buttons!